On Target Laboratories

About:

On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological

Website: https://ontargetlabs.com

Twitter/X: OnTargetLabs

Top Investors: H.I.G. Capital, Olympus Corporation of the Americas, Johnson & Johnson Innovation – JJDC, Johnson & Johnson Robotics and Digital Solutions, Elevate Ventures

Description:

On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010 and is based in Northbrook, Illinois.

Total Funding Amount:

$112M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Northbrook, Illinois, United States

Founded Date:

2010-01-01

Founders:

Philip Low

Number of Employees:

51-100

Last Funding Date:

2023-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai